Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Other Operating Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Other Operating Expenses for 5 consecutive years, with $32.1 million as the latest value for Q2 2020.

  • On a quarterly basis, Other Operating Expenses rose 97.94% to $32.1 million in Q2 2020 year-over-year; TTM through Dec 2020 was $31.2 million, a N/A change, with the full-year FY2024 number at $479000.0, changed N/A from a year prior.
  • Other Operating Expenses was $32.1 million for Q2 2020 at Forte Biosciences, up from -$885000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $32.1 million in Q2 2020 to a low of -$27.8 million in Q4 2019.
  • A 5-year average of $4.6 million and a median of $3.8 million in 2016 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: crashed 2776500.0% in 2019, then surged 97.94% in 2020.
  • Forte Biosciences' Other Operating Expenses stood at $1000.0 in 2016, then crashed by 200.0% to -$1000.0 in 2017, then changed by 0.0% to -$1000.0 in 2018, then plummeted by 2776500.0% to -$27.8 million in 2019, then surged by 215.45% to $32.1 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Other Operating Expenses are $32.1 million (Q2 2020), -$885000.0 (Q1 2020), and -$27.8 million (Q4 2019).